Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |